Subscapularis Repair During Reverse Total Shoulder Arthroplasty
Subscapularis Repair During Reverse Total Shoulder Arthroplasty: a Randomized Control Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Maywood, Illinois, United States, 60153
- Loyola Medicine
-
-
Michigan
-
Royal Oak, Michigan, United States, 48073
- Beaumont Health
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Primary RSA procedure with repairable (intact) SSc
- Operation will be performed by a participating surgeon using Zimmer Biomet Comprehensive Reverse Shoulder System implant
- Diagnosis with imaging of arthropathy with rotator cuff insufficiency
- Surgical approach: Deltopectoral
- Fluent English speakers/readers
Exclusion Criteria:
- Minor (<18 y/o)/vulnerable populations (pregnant women, prisoners, adults unable to consent)
- Revision surgery
- Oncologic surgery
- non-ZB CRSS implants
- Unrepairable SSc
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Subscapularis repair
Patients will undergo standard of care reverse total shoulder arthroplasty with subscapularis repair
|
To complete reverse total shoulder arthroplasty, the surgeon must cut through the subscapularis muscle.
In this arm of the study, the muscle will be repaired, rather than left to heal itself.
|
|
No Intervention: No repair
Patients will undergo standard of care reverse total shoulder arthroplasty.
The subscapularis will not be repaired.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The American Shoulder and Elbow Surgeons (ASES) Shoulder Score
Time Frame: up to 12 months post-surgery
|
Scored from 0 (worst shoulder condition) to 100 (best shoulder condition)
|
up to 12 months post-surgery
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Internal Rotator (IR) Strength
Time Frame: up to 12 months post-surgery
|
IR at the side and supported IR at 90˚ scapation; percent of nonsurgical side
|
up to 12 months post-surgery
|
|
PROMIS Bank v1.1 - Pain Interference
Time Frame: up to 12 months post-surgery
|
PROMIS measures generate T-scores.
T-scores are standard scores with a mean of 50 and standard deviation of 10 in a reference population (usually U.S. general population).
|
up to 12 months post-surgery
|
|
Shoulder Range of Motion
Time Frame: up to 12 months post-surgery
|
shoulder extension, flexion, internal rotation, abduction, adduction; percent of nonsurgical side
|
up to 12 months post-surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Guido Marra, MD, Northwestern University Feinberg School of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- STU00215591
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.